A Fred Hutch researcher speaks out on the human cost of the ‘unfettered, unbridled greed’ within our health care system
Feb. 11, 2016
| By Dr. Gary Lyman, as told to Diane Mapes
As an oncologist, I've had patients delay or actually stop treatment because of the high cost. They're stopping and they're dying as a result. That's why I've taken a stand with many of my colleagues around the country to call attention to these pricing issues and how unsustainable and devastating they are to our patients.
Cancer patients praise scathing report; experts from Fred Hutch, other top treatment centers decry cancer care's financial burden
July 23, 2015
| By Diane Mapes / Fred Hutch News Service
Cancer patients were quick to praise a scathing report from the country’s leading oncologists decrying the skyrocketing cost of cancer drugs. “[The report] is definitely a validation that these medications are ridiculously expensive,” said Erin Havel, a 38-year-old chronic myeloid leukemia patient from Seattle who had to declare bankruptcy due to the high cost of her cancer drugs. “Patients don’t really have much say. We should. We’re the consumers, but we’re more of a vehicle for companies to raise money. It feels like we’re a cash cow for Big Pharma.”
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.